210 related articles for article (PubMed ID: 33191095)
21. Glabridin inhibits the activation of myofibroblasts in human fibrotic buccal mucosal fibroblasts through TGF-β/smad signaling.
Lee PH; Chu PM; Hsieh PL; Yang HW; Chueh PJ; Huang YF; Liao YW; Yu CC
Environ Toxicol; 2018 Feb; 33(2):248-255. PubMed ID: 29119715
[TBL] [Abstract][Full Text] [Related]
22. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
[TBL] [Abstract][Full Text] [Related]
23. Depletion of miR-155 hinders the myofibroblast activities and reactive oxygen species generation in oral submucous fibrosis.
Chou MY; Fang CY; Hsieh PL; Liao YW; Yu CC; Lee SS
J Formos Med Assoc; 2022 Feb; 121(2):467-472. PubMed ID: 34274194
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of Notch Suppresses Epithelial-mesenchymal Transition and Induces Angiogenesis in Oral Submucous Fibrosis by Regulating TGF-β1.
Wang J; Yang L; Mei J; Li Z; Huang Y; Sun H; Zheng K; Kuang H; Luo W
Biochem Genet; 2024 Apr; 62(2):1055-1069. PubMed ID: 37526864
[TBL] [Abstract][Full Text] [Related]
25. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis.
Chang YC; Yang SF; Tai KW; Chou MY; Hsieh YS
Oral Oncol; 2002 Feb; 38(2):195-200. PubMed ID: 11854068
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of GMI, an immunomodulatory protein from Ganoderma microsporum, on myofibroblast activity and proinflammatory cytokines in human fibrotic buccal mucosal fibroblasts.
Lee PH; Hsieh PL; Liao YW; Yu CC
Environ Toxicol; 2018 Jan; 33(1):32-40. PubMed ID: 28984080
[TBL] [Abstract][Full Text] [Related]
27. LncRNA LINC00974 activates TGF-β/Smad signaling to promote oral fibrogenesis.
Fang CY; Yu CC; Liao YW; Hsieh PL; Lu MY; Lin KC; Wu CZ; Tsai LL
J Oral Pathol Med; 2019 Feb; 48(2):151-158. PubMed ID: 30447113
[TBL] [Abstract][Full Text] [Related]
28. miR-1246 as a therapeutic target in oral submucosa fibrosis pathogenesis.
Liu CM; Liao YW; Hsieh PL; Yu CH; Chueh PJ; Lin T; Yang PY; Yu CC; Chou MY
J Formos Med Assoc; 2019 Jul; 118(7):1093-1098. PubMed ID: 30928188
[TBL] [Abstract][Full Text] [Related]
29. The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline.
Yang SF; Tsai CH; Chang YC
J Oral Pathol Med; 2008 Apr; 37(4):206-10. PubMed ID: 18221324
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol inhibits arecoline-induced fibrotic properties of buccal mucosal fibroblasts via miR-200a activation.
Yang HW; Chun-Yu Ho D; Liao HY; Liao YW; Fang CY; Ng MY; Yu CC; Lin FC
J Dent Sci; 2024 Apr; 19(2):1028-1035. PubMed ID: 38618058
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of miR-29c promotes the progression of oral submucous fibrosis through targeting tropomyosin-1.
Yang PY; Ho DC; Chen SH; Hsieh PL; Liao YW; Tsai LL; Yu CC; Fang CY
J Formos Med Assoc; 2022 Jun; 121(6):1117-1122. PubMed ID: 34696938
[TBL] [Abstract][Full Text] [Related]
32. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
33. Regulation of hypoxia-inducible factor-1α in human buccal mucosal fibroblasts stimulated with arecoline.
Ho YC; Yang SF; Lee SS; Chang YC
J Formos Med Assoc; 2017 Jun; 116(6):484-487. PubMed ID: 28365254
[TBL] [Abstract][Full Text] [Related]
34. Arecoline stimulated early growth response-1 production in human buccal fibroblasts: suppression by epigallocatechin-3-gallate.
Hsieh YP; Chen HM; Chang JZ; Chiang CP; Deng YT; Kuo MY
Head Neck; 2015 Apr; 37(4):493-7. PubMed ID: 24436257
[TBL] [Abstract][Full Text] [Related]
35. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Hsieh YP; Wu KJ; Chen HM; Deng YT
J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
[TBL] [Abstract][Full Text] [Related]
36. miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis.
Zheng L; Jian X; Guo F; Li N; Jiang C; Yin P; Min AJ; Huang L
Oncol Rep; 2015 Jun; 33(6):2753-60. PubMed ID: 25872484
[TBL] [Abstract][Full Text] [Related]
37. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chou MY; Chang YC
Oral Oncol; 2003 Jun; 39(4):367-72. PubMed ID: 12676256
[TBL] [Abstract][Full Text] [Related]
38. LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis.
Lin CY; Liao YW; Hsieh PL; Lu MY; Peng CY; Chu PM; Yang HW; Huang YF; Yu CC; Yu CH
J Formos Med Assoc; 2018 Aug; 117(8):727-733. PubMed ID: 29249416
[TBL] [Abstract][Full Text] [Related]
39. Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosis.
Su TR; Liao YW; Hsieh PL; Tsai LL; Fang CY; Lin T; Lee YH; Harn HJ; Yu CC
Environ Toxicol; 2018 Jun; 33(6):686-694. PubMed ID: 29665273
[TBL] [Abstract][Full Text] [Related]
40. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis.
Tsai CH; Chou MY; Chang YC
J Oral Pathol Med; 2003 Mar; 32(3):146-53. PubMed ID: 12581384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
